We are live on
!
Find out more
BAMF
BI Asset Management Fondsmaeglerselskab Portfolio holdings
AUM
$12.6B
1-Year Est. Return
41.69%
This Fund
S&P 500
This Quarter
Est. Return
+12.86%
1 Year Est. Return
+41.69%
3 Year Est. Return
+134.93%
5 Year Est. Return
+172.69%
10 Year Est. Return
+588.15%
AUM
$2.3B
AUM Growth
+$94.4M
(+4.3%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
510
New
53
Increased
114
Reduced
178
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$32.7M |
| 2 |
AstraZeneca
AZN
|
+$26.9M |
| 3 |
TFI International
TFII
|
+$20.9M |
| 4 |
CVS Health
CVS
|
+$20.5M |
| 5 |
Comcast
CMCSA
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$33M |
| 2 |
Pfizer
PFE
|
+$28.2M |
| 3 |
Adobe
ADBE
|
+$9.97M |
| 4 |
Sysco
SYY
|
+$8.82M |
| 5 |
Magna International
MGA
|
+$8.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.04% |
| 2 | Healthcare | 16.42% |
| 3 | Consumer Discretionary | 12.7% |
| 4 | Financials | 12.48% |
| 5 | Consumer Staples | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
DTE Energy
DTE
$28.9B
| $26.2M | 1.14% |
253,550
-32,179
| -11% | -$3.39M |
|
27
Public Service Enterprise Group
PEG
$37.8B
| $25.8M | 1.13% |
443,382
-35,877
| -7% | -$2.09M |
|
28
Travelers Companies
TRV
$77.2B
| $25.5M | 1.11% |
181,691
-25,892
| -12% | -$3.33M |
|
|
29
AstraZeneca
AZN
$246B
| $25.4M | 1.1% |
+253,584
| New | +$26.9M |
|
30
Avery Dennison
AVY
$13.7B
| $25M | 1.09% |
161,469
-59,192
| -27% | -$8.57M |
|
31
Abbott
ABT
$192B
| $24.9M | 1.08% |
227,403
-31,848
| -12% | -$3.46M |
|
32
Tractor Supply
TSCO
$19B
| $24.8M | 1.08% |
880,745
-18,640
| -2% | -$522K |
|
|
33
CVS Health
CVS
$121B
| $24.5M | 1.07% |
359,023
+315,879
| +732% | +$20.5M |
|
34
Mastercard
MA
$490B
| $21.9M | 0.95% |
61,314
+19,535
| +47% | +$6.5M |
|
|
35
TFI International
TFII
$12B
| $21.7M | 0.94% |
+420,944
| New | +$20.9M |
|
36
Visa
V
$671B
| $20.5M | 0.89% |
93,828
-13,266
| -12% | -$2.71M |
|
37
JPMorgan Chase
JPM
$971B
| $19.7M | 0.86% |
154,991
+25,903
| +20% | +$2.9M |
|
38
NVIDIA
NVDA
$5.43T
| $18.4M | 0.8% |
1,411,280
+177,960
| +14% | +$2.38M |
|
39
Salesforce
CRM
$158B
| $18.3M | 0.8% |
82,249
+49,322
| +150% | +$12M |
|
40
Morgan Stanley
MS
$342B
| $16M | 0.7% |
233,337
+111,891
| +92% | +$6.42M |
|
41
Amgen
AMGN
$225B
| $15.4M | 0.67% |
66,973
+18,078
| +37% | +$4.17M |
|
42
Intel
INTC
$509B
| $15.1M | 0.66% |
302,711
-90,052
| -23% | -$4.4M |
|
43
Bristol-Myers Squibb
BMY
$130B
| $15M | 0.65% |
241,337
+61,620
| +34% | +$3.79M |
|
44
Cognizant
CTSH
$26.2B
| $13.9M | 0.6% |
169,150
+76,213
| +82% | +$5.8M |
|
|
MXIM
45
DELISTED
Maxim Integrated Products
MXIM
| $13.8M | 0.6% |
155,955
+134,784
| +637% | +$10.6M |
|
46
Tyson Foods
TSN
$19.6B
| $13.2M | 0.58% |
205,571
+153,358
| +294% | +$9.54M |
|
47
NetEase
NTES
$79.5B
| $13.1M | 0.57% |
136,908
+57,188
| +72% | +$5.13M |
|
|
SCHW
48
Charles Schwab
SCHW
$189B
| $12.9M | 0.56% |
243,891
+225,019
| +1,192% | +$10.2M |
|
49
Vertex Pharmaceuticals
VRTX
$133B
| $12.8M | 0.56% |
54,267
+30,501
| +128% | +$7M |
|
50
AbbVie
ABBV
$440B
| $12.8M | 0.56% |
119,659
-55,197
| -32% | -$5.3M |
|
Similar funds
ECM
LPC
ZIG
EIG
ZIM
AIM
PFPG
BI Asset Management Fondsmaeglerselskab's Q4 2020 Portfolio in Review
As of Q4 2020, BI Asset Management Fondsmaeglerselskab held 510 positions worth $2.3B, up 4.3% from $2.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
BI Asset Management Fondsmaeglerselskab withdrew a net $126M in Q4 2020, closing 133 positions and reducing 178 holdings. Its most notable exit was Infosys, an estimated $6.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, BI Asset Management Fondsmaeglerselskab opened a new position in AstraZeneca worth $25.4M.
- BI Asset Management Fondsmaeglerselskab's largest Q4 2020 buy was AstraZeneca: 253,584 shares worth $25.4M.
- BI Asset Management Fondsmaeglerselskab added most to Kimberly-Clark in Q4 2020, an estimated $32.7M increase.
- BI Asset Management Fondsmaeglerselskab's biggest Q4 2020 reduction was Paychex, cutting an estimated $33M.
- BI Asset Management Fondsmaeglerselskab fully exited Infosys in Q4 2020, selling an estimated $6.32M.
- BI Asset Management Fondsmaeglerselskab's ten largest holdings make up 25% of its $2.3B portfolio in Q4 2020.
- BI Asset Management Fondsmaeglerselskab opened 53 new positions and closed 133 in Q4 2020.
- BI Asset Management Fondsmaeglerselskab's portfolio value rose 4.3% quarter-over-quarter to $2.3B.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q4 2020, filed 12 Feb 2021.